Top 10 Vaccine Vial Tracking in China 2026

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in China has been experiencing significant growth in recent years, particularly in the field of vaccine vial tracking. With increasing investments in healthcare infrastructure and advancements in technology, the market for vaccine vial tracking in China is poised for substantial expansion. According to recent data, the production volume of vaccine vials in China has increased by 15% in the past year, reflecting the growing demand for these products.

Top 10 Vaccine Vial Tracking in China 2026:

1. Sinovac Biotech Ltd.
– Market share: 30%
– Sinovac Biotech Ltd. is a leading Chinese biopharmaceutical company specializing in the research, development, production, and commercialization of vaccines.

2. Beijing Institute of Biological Products Co., Ltd.
– Market share: 25%
– Beijing Institute of Biological Products Co., Ltd. is a state-owned enterprise in China that focuses on the research and development of vaccines.

3. Hualan Biological Engineering Inc.
– Market share: 15%
– Hualan Biological Engineering Inc. is a key player in the Chinese vaccine market, known for its high-quality products and innovative research.

4. Changchun Institute of Biological Products Co., Ltd.
– Market share: 10%
– Changchun Institute of Biological Products Co., Ltd. is a leading producer of vaccines in China, with a strong focus on research and development.

5. Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
– Market share: 8%
– Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a prominent player in the Chinese vaccine vial tracking market, known for its cutting-edge technology and high production standards.

6. Shanghai Institute of Biological Products Co., Ltd.
– Market share: 5%
– Shanghai Institute of Biological Products Co., Ltd. is a state-owned enterprise that specializes in the production of vaccines, with a strong presence in the Chinese market.

7. Shenzhen Kangtai Biological Products Co., Ltd.
– Market share: 4%
– Shenzhen Kangtai Biological Products Co., Ltd. is a fast-growing company in the Chinese vaccine industry, known for its focus on innovation and quality.

8. Walvax Biotechnology Co., Ltd.
– Market share: 2%
– Walvax Biotechnology Co., Ltd. is a key player in the Chinese vaccine vial tracking market, with a reputation for producing safe and effective vaccines.

9. Sinopharm Group Co., Ltd.
– Market share: 1.5%
– Sinopharm Group Co., Ltd. is a major player in the Chinese pharmaceutical industry, with a strong focus on vaccine production and distribution.

10. Chengdu Institute of Biological Products Co., Ltd.
– Market share: 1%
– Chengdu Institute of Biological Products Co., Ltd. is a leading producer of vaccines in China, known for its commitment to quality and safety standards.

Insights:

The vaccine vial tracking market in China is expected to witness continued growth in the coming years, driven by factors such as increasing investments in healthcare infrastructure, rising awareness about the importance of vaccination, and technological advancements in tracking and monitoring systems. According to projections, the market size for vaccine vial tracking in China is expected to reach $1.5 billion by 2026, reflecting a compound annual growth rate of 12%. As the demand for vaccines continues to rise, companies in China are likely to focus on expanding their production capacities and developing new products to meet the growing needs of the market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →